• Deutsch (DE-CH-AT)
  • English (United Kingdom)

NOTICE

with regard to the manufacturing license:
TICEBA
possesses the required authorization by the competent authority for the manufacturing of tissue as source material of human origin for the manufacturing of pharmaceuticals in accordance with § 20 b and § 20 c of the German Medicines Act: Authorization for the treatment or processing, preservation, storage of tissue or tissue preparations.

Future possibilities of application


In the future, tissue engineering, the reconstruction of organs or organ parts, will produce further and better approaches for the treatment of diseases in widely differing fields. Marred cells or cell structures are thereby renewed so that organs are able to again carry out their original function. One of the next steps will be the growth of whole organs and organ parts.


Future fields of application

Stroke: replacement of defective neuronal tissue
Heart attack: renewal of damaged heart muscle cells
Cardiac insufficiency: renewal of insufficient heart muscle tissue
Alzheimer's or Parkinson's disease: reproduction of neuronal cells
Disease of the pancreas (diabetes): growth of islet cells for insulin production
Muscle dystrophies: regeneration and build-up of musculature
Paraplegia: renewal of neural channels
Multiple Sclerosis: replacement of damaged neuronal cells

The described treatments are only a small insight into the diverse future application possibilities of stem cells due to tissue engineering.


NEWS

TICEBA receives SME eligibility of EMA. continue »
TICEBA now on facebook. continue »
next event:
29. - 31. May 2012, ECOPRAM - European Congress on Preventive, Regenerative and Anti-Aging Medicine, Istanbul (Turkey). Topic: "Autologous pluripotent mesenchymal stem cells from the skin". Booth: 12. continue »

NEWSLETTER

INFORMATIONS

Request any information from us now.

COUNSELLING

"We are glad to counsel you in person", Dr. Christoph Ganss:
+49 (0)6221.718 33 0